177 related articles for article (PubMed ID: 34595349)
1. A two-microRNA signature predicts the progression of male thyroid cancer.
Liu B; Shi H; Qiu W; Wu X; Li L; Wu W
Open Life Sci; 2021; 16(1):981-991. PubMed ID: 34595349
[TBL] [Abstract][Full Text] [Related]
2. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
Yang G; Zhang Y; Yang J
Front Oncol; 2019; 9():1207. PubMed ID: 31799184
[TBL] [Abstract][Full Text] [Related]
3. miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: The underlying molecular mechanisms.
Chen Q; Hu H; Jiao D; Yan J; Xu W; Tang X; Chen J; Wang J
Oncol Rep; 2016 Aug; 36(2):909-17. PubMed ID: 27277197
[TBL] [Abstract][Full Text] [Related]
4. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of two miRNAs promotes proliferation, hepatitis B virus amplification, migration and invasion of hepatocellular carcinoma cells: evidence from bioinformatic analysis and experimental validation.
Liu Y; Cao Y; Cai W; Wu L; Zhao P; Liu XG
PeerJ; 2020; 8():e9100. PubMed ID: 32377460
[TBL] [Abstract][Full Text] [Related]
6. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
Zheng L; Wang J; Jiang H; Dong H
Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA analysis of childhood atopic dermatitis reveals a role for miR-451a.
Nousbeck J; McAleer MA; Hurault G; Kenny E; Harte K; Kezic S; Tanaka RJ; Irvine AD
Br J Dermatol; 2021 Mar; 184(3):514-523. PubMed ID: 32478410
[TBL] [Abstract][Full Text] [Related]
8. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.
Wu K; Zhang C; Zhang C; Dai D
Biomed Res Int; 2020; 2020():5973082. PubMed ID: 32104700
[TBL] [Abstract][Full Text] [Related]
9. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y
Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551
[TBL] [Abstract][Full Text] [Related]
10. Study on miRNAs in Pan-Cancer of the Digestive Tract Based on the Illumina HiSeq System Data Sequencing.
Lai CH; Liang XZ; Liang XY; Ma SJ; Li JG; Shi MF; Zhu X; Lan HH; Zeng JH
Biomed Res Int; 2019; 2019():8016120. PubMed ID: 31737678
[TBL] [Abstract][Full Text] [Related]
11. Identification of Prognostic miRNA Signature and Lymph Node Metastasis-Related Key Genes in Cervical Cancer.
Chen S; Gao C; Wu Y; Huang Z
Front Pharmacol; 2020; 11():544. PubMed ID: 32457603
[TBL] [Abstract][Full Text] [Related]
12. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
13. Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis.
Ab Mutalib NS; Othman SN; Mohamad Yusof A; Abdullah Suhaimi SN; Muhammad R; Jamal R
PeerJ; 2016; 4():e2119. PubMed ID: 27350898
[TBL] [Abstract][Full Text] [Related]
14. Screening and identification of differentially expressed microRNAs in diffuse large B-cell lymphoma based on microRNA microarray.
Gao HX; Li SJ; Wang MB; Yan SF; Cui WL; Ma ZP; Xue J; Sang W; Zhang W; Li XX
Oncol Lett; 2021 Nov; 22(5):753. PubMed ID: 34539857
[TBL] [Abstract][Full Text] [Related]
15. Identification of a MicroRNA Signature Associated With Lymph Node Metastasis in Endometrial Endometrioid Cancer.
Fu K; Li Y; Song J; Cai W; Wu W; Ye X; Xu J
Front Genet; 2021; 12():650102. PubMed ID: 33936173
[TBL] [Abstract][Full Text] [Related]
16. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
17. Three-microRNA expression signature predicts survival in triple-negative breast cancer.
Wu X; Ding M; Lin J
Oncol Lett; 2020 Jan; 19(1):301-308. PubMed ID: 31897142
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR‑193a‑3p via targeting cyclin D1 in thyroid cancer.
Li XJ; Wen R; Wen DY; Lin P; Pan DH; Zhang LJ; He Y; Shi L; Qin YY; Lai YH; Lai JN; Yang JL; Lai QQ; Wang J; Ma J; Yang H; Pang YY
Mol Med Rep; 2020 Sep; 22(3):2199-2218. PubMed ID: 32705210
[TBL] [Abstract][Full Text] [Related]
20. Identification of invasion-metastasis associated MiRNAs in gallbladder cancer by bioinformatics and experimental validation.
Cao J; Shao H; Hu J; Jin R; Feng A; Zhang B; Li S; Chen T; Jeungpanich S; Topatana W; Tian Y; Lu Z; Cai X; Chen M
J Transl Med; 2022 Apr; 20(1):188. PubMed ID: 35484565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
